Release Date: 08/05/14 08:42 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 107.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%